Weekly Roundup
COVID-19 Vaccine Development, Policy, and Public Perception in the United States
|
|
CommuniVax Corner
NEW: ISU researchers provide valuable insight into Hispanic vaccination access. When Johns Hopkins’s Communivax Coalition began searching for researchers to examine access to COVID-19 vaccines in underserved populations in order to guide pandemic response efforts, Idaho State University stepped up to provide a picture of vaccination in Southeast Idaho’s rural Hispanic community. At the beginning of January 2021, researchers from the College of Arts and Letters and the Division of Health Sciences teamed up and assembled 20 anthropology, Spanish, public health, premedical and nursing students to gather data and be listed as co-authors on the final report. This data was then used to make recommendations for the continuing response to the COVID pandemic. (Idaho State University, 10/19/21)
|
|
People, Perceptions, and Polls
|
|
RESEARCH
Christian nationalism and COVID-19 vaccine hesitancy and uptake. Using a new nationally representative sample of U.S. adults, we find that Christian nationalism is one of the strongest predictors of COVID-19 vaccine hesitancy and is negatively associated with having received or planning to receive a COVID-19 vaccine. Since Christian nationalists make up approximately 20 percent of the population, these findings could have important implications for achieving herd immunity. (Vaccine, 10/29/21)
|
|
NEWS
COVID-19 and pregnancy: Women regret not getting the vaccine. Since the pandemic began, health officials have reported more than 125,000 cases and at least 161 deaths of pregnant women from COVID-19 in the U.S., according to the U.S. Centers for Disease Control and Prevention. And over the past several months, hospitals and doctors in virus hot spots have reported a sharp increase in the number of severely ill pregnant women. (AP, 10/19/21)
|
|
WEBINAR
Behind the Numbers: Building Community Trust in Vaccination. Join a panel of experts, advocates, and community ambassadors for a 60-minute webinar hosted by the International Vaccine Access Center to discuss the VALUE Baltimore project. For VALUE, which stands for Vaccine Acceptance & Access Lives in Unity, Education & Engagement, communities are central partners in vaccine policy. Panelists will discuss elements of Baltimore’s success in reaching nine VALUE communities as well as remaining challenges, such as attaining an 80% COVID-19 vaccine coverage rate while building trust in communities that face tough challenges well beyond the pandemic. The webinar will take place on October 26, 2021, 12 PM ET . (IVAC, 10/21)
|
|
Law, Policy, and Politics
|
|
Research, Development, and Clinical Practice
|
|
NEWS
FDA clears Johnson & Johnson and Moderna booster shots for millions of people. The ruling will now be handed off to the Centers for Disease Control and Prevention and its vaccine advisory committee, which has scheduled a meeting Thursday to discuss Moderna and J&J’s booster data. If the committee issues a recommendation, and CDC Director Dr. Rochelle Walensky signs off, additional shots for those vaccines could be distributed immediately to eligible people . (CNBC, 10/20/21)
|
|
NEWS
More Covid Vaccine Boosters Are Coming. Who Should Get Them? In the next few days, an advisory committee to the Centers for Disease Control and Prevention is expected to debate who should receive booster shots for the Moderna and Johnson & Johnson vaccines, a follow-up to last week’s Food and Drug Administration committee meeting. By the end of this week, if those agencies’ directors approve, many millions more Americans should be eligible to receive additional shots . (Wired, 10/20/21)
See also:
|
|
This newsletter supports CommuniVax, a research coalition convened by the
Johns Hopkins Center for Health Security and the Texas State University Department of Anthropology,
with support from the Chan Zuckerberg Initiative and The Rockefeller Foundation.
|
|
|
|
|
|
|